MESTEX
Mestex is one of the important clusters for innovative pharmaceutical industries and biotech companies in Europe. Mestex AG is a Swiss biotech company that has developed the innovative investigational medicine MTX-071 (resiniferatoxin) for the intra-articular treatment of pain associated with osteoarthritis of the knee.
MESTEX
Industry:
Biotechnology Pharmaceutical
Address:
Basel, Basel-Stadt, Switzerland
Country:
Switzerland
Website Url:
http://www.mestex.ch
Status:
Active
Email Addresses:
[email protected]
Technology used in webpage:
SPF Microsoft Exchange Online Microsoft Azure DNS Microsoft Microsoft Azure Microsoft Azure Europe North Region MarkMonitor DNS
Similar Organizations
Klinikos
Klinikos is Expertise in Resourcing for Field Based Activities of a Clinical Trial in Europe.
Labtech
Labtech is a supplier and service provider for highly innovative scientific instruments and consumables.
Lonza
Lonza Group supplies products and services to pharmaceutical and agrochemical industries.
ProsCon Ltd
ProsCon Ltd is primarily serves major customers in the pharmaceutical and biotechnology markets.
University of Cologne
University of Cologne is the sixth oldest university in Central Europe with more than 48,000 students.
More informations about "Mestex"
Mestex - Crunchbase Company Profile & Funding
Mestex AG is a Swiss biotech company that has developed the innovative investigational medicine MTX-071 (resiniferatoxin) for the intra-articular treatment of pain associated with …See details»
Mestex AG - Life-Sciences-Europe.com
Jan 1, 2014 · Mestex AG is a Swiss biotech company that has developed the innovative investigational medicine MTX-071 (resiniferatoxin) for the intra-articular treatment of pain …See details»
Acquisition of Mestex AG 12.04.2021
Apr 12, 2021 · By acquiring the Swiss biotech company Mestex AG and the global rights for its innovative investigational medicine MTX-071 (Resiniferatoxin), Grünenthal has recently …See details»
Grünenthal acquires Mestex AG
With the acquisition of Mestex AG, Grünenthal secures global rights for an attractive late-stage asset that could offer an innovative therapy option for millions of patients affected by pain …See details»
Mestex AG - Ownership and Business Overview - Mergr
Apr 12, 2021 · Mestex is a cluster for innovative pharmaceutical industries and biotech companies in Europe. The company with its brand Lopain provides solutions to all patients suffering from …See details»
Organization | Mestex AG
Mestex AG Report issue For profit Phase 1 Founded: Basel Switzerland (1996)See details»
Grünenthal erwirbt die Mestex AG und ihren …
Apr 12, 2021 · Die Mestex AG ist ein Schweizer Biotech-Unternehmen, das den innovativen Arzneimittelkandidaten MTX-071 (Resiniferatoxin) für die intraartikuläre Behandlung von …See details»
Press Release GRÃœNENTHAL
Aachen, Germany, 12 April 2021 – Today, Grünenthal has announced the acquisition of Mestex AG through the takeover of all of its shares and options. Mestex AG is a Swiss biotech …See details»
Grünenthal acquires Mestex AG and its Phase-III-ready …
Apr 12, 2021 · Mestex AG is a Swiss biotech company that has developed the innovative investigational medicine MTX-071 (resiniferatoxin) for the intra-articular treatment of pain …See details»
The Grunenthal Group acquires Mestex - 2021-04-12 - Crunchbase
Apr 12, 2021 · Grünenthal acquires Mestex AG and its Phase-III-ready investigational medicine MTX-071 for the treatment of pain associated with osteoarthritis of the kneeSee details»
Mestex - Products, Competitors, Financials, Employees, …
Mestex is a biotech company developing medicine that aims to treat osteoarthritis. On April 12, 2021, Mestex was acquired by Grunenthal Group. Use the CB Insights Platform to explore …See details»
Mestex - Overview, News & Similar companies | ZoomInfo.com
View Mestex (www.mestex.ch) location in Basel-City, Switzerland , revenue, industry and description. Find related and similar companies as well as employees by title and much more.See details»
Mestex AG - life-sciences-europe.com
Upcoming Events. ADLM 2024 Annual Meeting & Clinical Lab Expo Chicago (formerly AACC 2024) IMSC 2024 Melbourne; Pharmatech & Health East Africa 2024 with Medical & Lab East …See details»
Grünenthal acquires Swiss biotech company Mestex
Apr 14, 2021 · Mestex AG is a Swiss biotech company that has developed the innovative investigational medicine MTX-071 (resiniferatoxin) for the intra-articular treatment of pain …See details»
Mestex AG - Drug pipelines, Patents, Clinical trials - Synapse
As a science-based, privately-owned pharmaceutical company, we have a long track record of bringing innovative treatments and state-of-the-art technologies to patients worldwide. Our …See details»
Board of Directors - T3 Pharma
After several years of collaboration with venture capital groups (e.g. Endeavour Vision in Geneva), he joined Mestex in 2014 as CEO. Frank is the Global Head of the Boehringer Ingelheim …See details»
Mestex - Crunchbase Company Profile & Funding
Mestex manufacturers HVAC with air handling. Their products, including HVAC systems from applied air, alton, aztec, koldwave, sierra, temprite, and lj wing, are equipped with industry …See details»
Mestex achieves ISO 14001-2015 Certification - ACHR News
Jun 9, 2016 · Mestex announced it has achieved International Organization for Standardization (ISO) 14001-2015 certification for environmental management systems.See details»
Mestex - LinkedIn
At Mestex, we believe that diverse teams foster innovation, creativity, and success. Our workforce is a vibrant tapestry of talents, backgrounds, and experiences, reflecting the richness of the...See details»
Mestex, a Division of Mestek Inc. - LinkedIn
Jun 7, 2016 · Dallas, TX – Mestex, an HVAC manufacturer for industrial and other commercial applications, today announced it has achieved International Organization for Standardization …See details»